Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. filed an 8-K current report on December 29, 2023, under the SPAC ticker LACQ, associated with Leisure Acquisition Corp., a blank-check company that completed its IPO in 2019. Originally targeting the entertainment and gaming industries, Leisure Acquisition Corp. subsequently combined with Ensysce Biosciences, a pharmaceutical developer focused on abuse-deterrent opioid and stimulant drug technologies; the de-SPAC transaction closed in 2021. By the time of this December 2023 filing, the post-merger entity operated within the healthcare and life sciences sector under ongoing public-company reporting obligations. For full filing history, sponsor details, and deal analytics on LACQ and thousands of other SPACs, create your free account at SpacDesk.